Medscape

Colorectal cancer in the United States continues to move in two different directions — decreasing in older adults and rising in younger adults, especially in those aged 20-49 years, according to the latest statistics from the American Cancer Society. The ACS report, published online earlier this month, revealed that CRC incidence rates declined by 2.5% annually in adults age 65 years and older but increased by 3% annually in adults aged 20-49 between 2013 and 2022 — higher than earlier estimates of 1%-2% annual increases. The trends are “concerning” and a “stark reminder that we’re seeing a shifting epidemiology,” said Folasade (Fola) May, MD, PhD, MPhil, director of the gastroenterology quality improvement program at UCLA Health in Los Angeles, who wasn’t involved in the analysis. mdsc.pe/4bAN3X8

Stay current on HCM care! Explore the latest updates on CMI therapy and emerging treatment strategies. Learn how new evidence can guide individualized approaches and optimize patient outcomes. ▶️ mdsc.pe/4txFKI1

📣 Invite your patients living with systemic mastocytosis An in-person Community Exchange with @KuykendallMd—designed for connection, shared experiences, and peer support in a safe, small-group setting. 🍽️ Dinner provided | Spots limited 🔗 mdsc.pe/40A4odX

Emergency doctors warned MPs that unsafe A&E conditions and corridor care are leaving staff exposed to rising violence. mdsc.pe/3NPfIjp

A growing debate is emerging as continuous glucose monitoring (CGM) gains traction. While A1C remains a simple, standardized measure of average glucose over time, CGM offers real-time insights into glucose variability, time in range, and hypoglycemia risk. Experts note that each has strengths and limitations: A1C is widely accessible and well-validated, whereas CGM requires devices, training, and ongoing data management. The takeaway? Many clinicians say it’s not about choosing one over the other — but using both together to get a more complete picture of glycemic control. mdsc.pe/4bXn2BR

A sugar solution placed in the mouth before a needle insertion likely curbs newborns’ pain, according to a new Cochrane review. The finding — combined with a 2023 Cochrane review and others — suggests that the longstanding practice now has enough evidence to be standardized across hospitals and used as a “gold standard” in clinical trials, the researchers said. It also adds to growing research on the effects of nonpharmacologic pain interventions for infants — and hints at lingering gaps in our understanding of how babies process pain. mdsc.pe/4bTt9Ic

Nearly every physician eventually faces a malpractice claim — and the raw emotions that come with it. Here’s how to cope with the shock, fear, and anger: mdsc.pe/4sDMXWl

New guidance on the use of GLP-1-based drugs in people with type 1 diabetes (T1D), due to be published later this year, will address the safety and optimal use of these medications which are currently used off-label in this patient population. Although the use is off-label, it has been increasing in recent years, particularly as an adjunct to insulin in people with T1D who also have obesity and/or cardiovascular disease. mdsc.pe/4rM8vPd

Starting in 1 HOUR ➡️ youtube.com/watch?v=SxYDLq… Is your practice ready to operationalize AID for Type 2 Diabetes? Join our live social event to explore real-world solutions AND earn free CME credit. See you there! #CME #T2DMythBusters

A major meta-analysis led by Jack Wilson, PhD, of the University of Sydney found little reliable evidence that cannabinoids effectively treat most psychiatric conditions or substance use disorders. The review showed no benefit for anorexia nervosa, anxiety, PTSD, or opioid use disorder, and insufficient data for ADHD, depression, OCD, and bipolar disorder. Some improvement was seen for cannabis withdrawal, Tourette syndrome, insomnia, and autism traits, but overall evidence quality was low. mdsc.pe/4sheT1N

US weekly magazine Newsweek and data platform Statista have published their annual ranking of the World’s Best Hospitals — regardless of specialty — for the eighth time. The Mayo Clinic in Rochester, Minnesota, ranked No. 1 for the fifth straight year. There were changes, however, just behind it: Toronto General Hospital and the Cleveland Clinic swapped places at No. 2 and No. 3. Stockholm’s Karolinska University Hospital also improved by one spot to No. 4, making it the highest-ranked hospital in Europe. mdsc.pe/4bwSAOv

People who received outpatient vision rehabilitation and had hearing impairment were older and in poorer physical health than those with normal hearing. They were also less likely to achieve meaningful functional gains from the rehabilitation. mdsc.pe/40zbEGZ

The American Headache Society (AHS) is recommending annual screening for migraine as part of routine preventive care for girls and women — from adolescence through menopause Despite its high prevalence — especially among girls and women — and substantial negative impacts, migraine is “under diagnosed and under treated. mdsc.pe/4sSg9Ze

Greater awareness of neurodivergence in medicine is prompting debate about stigma, workplace support, and clinician well-being. mdsc.pe/4bD42IF

Unmet healthcare needs among children with autism spectrum disorder increased from 2016 to 2023, with a slight drop in 2020 followed by a rise in 2023. Unmet mental health care needs surged in 2020 and then stabilized. mdsc.pe/3NdHu9b

Microbiome-modulating therapies, including prebiotics, probiotics, and postbiotics, are safe and associated with “clinically meaningful” lesion reductions in patients with acne, according to a recently published systematic review. Among these therapies, “probiotics currently have the strongest evidence base, while prebiotics and postbiotics are promising adjuncts,” the authors from the Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, wrote in the review, published online in Dermatology and Therapy. mdsc.pe/41gxMpC

Delaying in-hospital blood draws by just 2 hours helped sleep quality and quantity, researchers find. Now, some hospitals are considering a change to traditional timing. mdsc.pe/4bQVjUc

Most older adults with advanced cancer care more about the quality of their remaining life than the quantity, but those priorities do not seem to alter their up-front care or their outcomes, according to a new study. The findings, published in JAMA Oncology, raise questions about whether oncology care teams are considering and responding to the personal goals of older patients with incurable cancers. mdsc.pe/40I7dcS

Initiation of menopausal hormone therapy (HT) after age 65 is linked to significantly increased risks for cancer and vascular events, new data suggested. A study of more than 80,000 women aged 50 years or older in an Israeli health system during 2000-2022 showed that HT use overall was associated with several types of hormone-sensitive and nonhormone-sensitive cancers. While HT offered some cardiovascular benefit when started at age 50-65, it also raised stroke and cancer risks. And HT initiated in those aged 65 years or older significantly raised the risk for both cancer and cerebrovascular events. mdsc.pe/4tcCwJd

How do you build trust when patients believe misinformation? Experts say it starts with listening — not correcting. Taking time to understand where patients are getting information and acknowledging their concerns can open the door to more productive conversations. From there, clinicians can gently share evidence, clarify misconceptions, and focus on shared decision-making rather than confrontation. mdsc.pe/4lxUN0I